FOX
55
2
HUM
36
-3
MAS
54
3
ORCL
59
3
FIS
84
-3
FMC
43
3
AMAT
52
2
MAR
54
12
HES
52
2
NWS
96
4
PVH
44
-8
ZION
63
2
MMC
57
4
WDC
41
3
GOOG
65
-2
BBY
48
3
XRX
31
6
CSCO
64
13
MCD
52
2
ICE
69
2
FOX
55
2
HUM
36
-3
MAS
54
3
ORCL
59
3
FIS
84
-3
FMC
43
3
AMAT
52
2
MAR
54
12
HES
52
2
NWS
96
4
PVH
44
-8
ZION
63
2
MMC
57
4
WDC
41
3
GOOG
65
-2
BBY
48
3
XRX
31
6
CSCO
64
13
MCD
52
2
ICE
69
2
Financhill
Back

Ameriprise Financial Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
66

AMP
Ameriprise Financial

Last Price:
$466.03
Seasonality Move:
1.13%
Sell
46

ALNY
Alnylam Pharmaceuticals

Last Price:
$251.70
Seasonality Move:
20.34%
Buy
66
Ameriprise Financial (AMP) is a Buy

Is Ameriprise Financial a Buy, Sell or Hold?

  • The current Ameriprise Financial [AMP] share price is $465.94. The Score for AMP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AMP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $251.56. The Score for ALNY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AMP Stock Price Chart

What is Ameriprise Financial's stock price today?

  • The Ameriprise Financial share price today is $465.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMP is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $251.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AMP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.89 Sell
Relative Strength Index (14 RSI): 46.92 Sell
Chaikin Money Flow: -358347 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (448.7 - 495.64) Sell
Bollinger Bands (100): (483.23 - 555.87) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.62 Sell
Relative Strength Index (14 RSI): 53.73 Buy
Chaikin Money Flow: 623017 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (231.11 - 269.73) Buy
Bollinger Bands (100): (237.02 - 266.92) Sell

AMP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 466.86 Sell
20-day SMA: 464.45 Buy
50-day SMA: 493.12 Sell
200-day SMA: 494.43 Sell
8-day EMA: 466.93 Sell
20-day EMA: 470.16 Sell
50-day EMA: 488.12 Sell
200-day EMA: 488.62 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 237.7 Buy
20-day SMA: 243.26 Buy
50-day SMA: 249.78 Buy
200-day SMA: 258.61 Sell
8-day EMA: 241.27 Buy
20-day EMA: 243.27 Buy
50-day EMA: 248.83 Buy
200-day EMA: 244.06 Buy

Ameriprise Financial Earnings Growth & AMP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.79 per share, an increase this year of $2.22 per share, and an increase next year of $2.68 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $1.38 per share, an increase this year of $0.96 per share, and an increase next year of $2.88 per share.

Ameriprise Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):